1,233 results on '"Perrie, Yvonne"'
Search Results
2. Higher or lower?: The resolution of analytical pipelines for the evaluation of lipid nanoparticle critical quality attributes
3. Assessing lipid nanoparticle protein corona formation and cytocompatibility
4. Use of Nanotechnology in the Formulation of Vaccines
5. Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective
6. The influence of citrate buffer molarity on mRNA-LNPs: Exploring factors beyond general critical quality attributes
7. Nanoparticle Isolation from Biological Media for Protein Corona Analysis: The Impact of Incubation and Recovery Protocols on Nanoparticle Properties
8. Investigating the impact of shear flow on nanoparticle-protein interactions
9. Enhancing Transfection Efficacy in Glioma Cells: A Comparison of Microfluidic versus Manual Polypropylenimine Dendriplex Formation.
10. Targeting circulating monocytes with CCL2-loaded liposomes armed with an oncolytic adenovirus
11. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency
12. Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems
13. Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses
14. Can We Simplify Liposome Manufacturing Using a Complex DoE Approach?
15. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection
16. Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes
17. The Role of Biological Sex in Pre-Clinical (Mouse) mRNA Vaccine Studies
18. Introducing RSC Pharmaceutics
19. Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics
20. A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations
21. Formulation and manufacturing of lymphatic targeting liposomes using microfluidics
22. Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments
23. Particle Size Analysis of Micro and Nanoparticles
24. In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particles
25. Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01
26. High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
27. Developing Bilayer-Based Delivery Systems for Oral Delivery of Subunit Vaccines
28. The Application of Liposomes as Vaccine Adjuvants
29. Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreatic cancer therapy
30. Nanoparticle isolation from biological media for protein corona analysis: The impact of incubation and recovery protocols on nanoparticle attributes
31. Development of a solid dosage platform for the oral delivery of bilayer vesicles
32. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability
33. Evaluation of anti-biofilm activity of acidic amino acids and synergy with ciprofloxacin on Staphylococcus aureus biofilms
34. Formulation and Characterisation of PLGA Microspheres as Vaccine Adjuvants
35. Immunomic Discovery of Adjuvants, Delivery Systems, and Candidate Subunit Vaccines: A Brief Introduction
36. Designing Nonionic Surfactant Vesicles for the Delivery of Antigens for Systemic and Alternative Delivery Routes
37. Designing Liposomes as Vaccine Adjuvants
38. Liposomes as a gene delivery system
39. Evaluating the impact of experimental shear flow parameters on nanoparticle protein corona formation
40. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile
41. Designing liposomal adjuvants for the next generation of vaccines
42. Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics
43. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets
44. Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles
45. A pragmatic approach for engineering porous mannitol and mechanistic evaluation of particle performance
46. Vaccines
47. Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics
48. Point of use production of liposomal solubilised products
49. Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infections
50. Preparation of Zein-Based Nanoparticles: Nanoprecipitation versus Microfluidic-Assisted Manufacture, Effects of PEGylation on Nanoparticle Characteristics and Cellular Uptake by Melanoma Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.